Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Despite growing interest, it is important to understand that BPC-157 is not a standalone solution or a replacement for conventional medical care
Bacteriophages in gut samples from pediatric Crohns disease patients: metagenomic analysis using 454 pyrosequencing
Mol Nutr Food Res 60 , 10901098, (2016)
International Regulatory Landscape Healthcare Provider Considerations Healthcare providers who prescribe or recommend BPC-157 face potential: Disciplinary action from state medical boards Medical license implications (sanctions, restrictions, suspension) Malpractice liability (insurance often excludes experimental treatments) Federal regulatory enforcement Research and Access Legitimate research pathways: Investigational New Drug (IND) application required for human research Institutional Review Board (IRB) approval required GMP standards required for research-grade materials Current access: Research peptide suppliers (variable quality) Some compounding pharmacies (legal status varies) Clinical trials (limited availability) Why This Regulatory Status Exists BPC-157's prohibition stems from: Limited clinical data Only small pilot studies published (~28 human subjects total)
US$ 21.19
US$ 26.37
US$ 27.54
US$ 25.14
US$ 23.05